Legal & General Group »

Galectin Therapeutics shares owned by Legal & General Group

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Legal & General Group from 13F filings

Historical chart of Legal & General Group investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Legal & General Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $22k 4.7k 4.64
2025-03-31 $45 38 1.21
2024-12-31 $3.2k 2.5k 1.29
2024-09-30 $6.8k 2.5k 2.75
2024-06-30 $5.6k 2.5k 2.26
2021-03-31 $10k 4.6k 2.20
2020-12-31 $10k 4.6k 2.20
2020-09-30 $12k 4.6k 2.64
2020-06-30 $20k 6.5k 3.06
2020-03-31 $13k 6.9k 1.89
2019-12-31 $27k 9.3k 2.91
2019-09-30 $28k 7.7k 3.65
2019-06-30 $22k 5.4k 4.10